Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

In This Issue   |    
In This Issue
Am J Psychiatry 2013;170:A20-A20. doi:10.1176/appi.ajp.2012.17010issue
View Author and Article Information

Copyright © 2013 by the American Psychiatric Association

Anchor for JumpAnchor for Jump
James H. Scully Jr., M.D., will step down as APA Medical Director and CEO at the end of 2013 (Freedman, p. 1113)

Clinical Guidance: Intravenous Ketamine’s Brief Antidepressant Effect 

Intravenous ketamine administered to depressed patients who had not responded to at least three previous antidepressants improved depression in 64% of patients 24 hours after a single dose, compared to 28% of patients who received the anesthetic midazolam. The 73 patients studied by Murrough et al. (p. 1134) were carefully screened to exclude those with substance abuse, psychotic illness, suicide risk, and unstable medical conditions. Dissociative symptoms, such as feeling outside one’s body, occurred in 17% of the ketamine group, and blood pressure changes in two patients required termination of the infusion. Depression scores did not differ between treatment groups 7 days after the infusion. Ketamine is not ready for clinical use, states Rush in an editorial (p. 1079), but it is a promising lead for new therapeutic development.

Oxytocin’s influence on social behavior extends to the pathophysiology and treatment of psychiatric disorders. Apter-Levy et al. (CME, p. 1161) discovered that low salivary oxytocin levels in chronically depressed mothers and their families were associated with the GG genotype for an oxytocin receptor gene (OXTR) variant in the mother. The GG genotype was overrepresented in depressed mothers and their children, but the children’s high psychopathology levels were buffered by the presence of at least one A allele. Bertsch et al. (p. 1169) tested intranasal oxytocin as a treatment for social threat hypersensitivity. While viewing pictures of angry faces, untreated women with borderline personality disorder had more changes in visual fixation and greater amygdala activation than healthy women, but patients given oxytocin had normal responses. Impaired social cognition is common to many psychiatric disorders, notes Hollander in an editorial (p. 1086), and specific domains, such as social reward and eye gaze, may make useful research targets for oxytocin.

Clinical Guidance: Responses to Sweet Taste in Eating Disorders 

Appreciation of abnormal brain activation to food in anorexia nervosa or bulimia nervosa, even after recovery, may help patients understand its pathological mechanisms. Oberndorfer et al. (p. 1143) demonstrated that in response to the taste of sugar, the brain’s higher center for taste processing, the anterior insula, activated less in women recovered from anorexia nervosa than in healthy women. Conversely, women recovered from bulimia nervosa had exaggerated responses. An attenuated response to food might call for small meals throughout the day, whereas help to cope with excessive activation might combat purging. A study of brain structure by Frank et al. (CME, p. 1152) found associations between sweet taste and the volume of brain regions related to both taste and reward sensitivity in both anorexia nervosa and bulimia nervosa. In an editorial, Alonso-Alonso (p. 1082) distinguishes between “liking” and “wanting” food, noting that both healthy subjects and eating disorder patients considered the sweet taste to be pleasant but that the patients had higher sensitivity to it as a reward.

Clinical Guidance: Severe Irritability in Children 

The behavioral responses to frustration in children with severe, chronic irritability are mirrored by abnormal neural responses. Deveney et al. (CME, p. 1186) report that brain regions implicated in emotion, spatial attention, and reward processing show less activation after negative feedback in frustrating situations among children with severe mood dysregulation than among healthy children. Children with severe mood dysregulation also exhibit difficulty in shifting attention. Ryan points out in an editorial (p. 1093) that the findings may apply to other disorders, since irritability spans multiple diagnoses.

James H. Scully Jr., M.D., will step down as APA Medical Director and CEO at the end of 2013 (Freedman, p. 1113)



CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe